136 related articles for article (PubMed ID: 34375974)
21. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
22. Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.
Zhang JM; Feng FE; Wang QM; Zhu XL; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
Stem Cells Transl Med; 2016 Dec; 5(12):1631-1643. PubMed ID: 27471307
[TBL] [Abstract][Full Text] [Related]
23. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53.
Zhang J; Huang K; O'Neill KL; Pang X; Luo X
Cell Death Dis; 2016 Jun; 7(6):e2266. PubMed ID: 27310874
[TBL] [Abstract][Full Text] [Related]
24. Detection of various platelet-associated immunoglobulins by flow cytometry in idiopathic thrombocytopenic purpura.
Nishioka T; Yamane T; Takubo T; Ohta K; Park K; Hino M
Cytometry B Clin Cytom; 2005 Nov; 68(1):37-42. PubMed ID: 16184616
[TBL] [Abstract][Full Text] [Related]
25. Investigation of megakaryocyte apoptosis in children with acute and chronic idiopathic thrombocytopenic purpura.
Uçar C; Oren H; Irken G; Ateş H; Atabay B; Türker M; Vergin C; Yaprak I
Eur J Haematol; 2003 Jun; 70(6):347-52. PubMed ID: 12756015
[TBL] [Abstract][Full Text] [Related]
26. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
[TBL] [Abstract][Full Text] [Related]
27. Intrinsic apoptosis circumvents the functional decline of circulating platelets but does not cause the storage lesion.
Pleines I; Lebois M; Gangatirkar P; Au AE; Lane RM; Henley KJ; Kauppi M; Corbin J; Cannon P; Bernardini J; Alwis I; Jarman KE; Ellis S; Metcalf D; Jackson SP; Schoenwaelder SM; Kile BT; Josefsson EC
Blood; 2018 Jul; 132(2):197-209. PubMed ID: 29784641
[TBL] [Abstract][Full Text] [Related]
28. Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction.
Seo SK; Lee HC; Woo SH; Jin HO; Yoo DH; Lee SJ; An S; Choe TB; Park MJ; Hong SI; Park IC; Rhee CH
Apoptosis; 2007 Jan; 12(1):195-209. PubMed ID: 17136320
[TBL] [Abstract][Full Text] [Related]
29. Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura.
Peerschke EI; Andemariam B; Yin W; Bussel JB
Br J Haematol; 2010 Feb; 148(4):638-45. PubMed ID: 19925495
[TBL] [Abstract][Full Text] [Related]
30. Platelet microparticles in immune thrombocytopenic purpura in pediatrics.
Tantawy AA; Matter RM; Hamed AA; Shams El Din El Telbany MA
Pediatr Hematol Oncol; 2010 May; 27(4):283-96. PubMed ID: 20426519
[TBL] [Abstract][Full Text] [Related]
31. Reduced intracellular antioxidant capacity in platelets contributes to primary immune thrombocytopenia via ROS-NLRP3-caspase-1 pathway.
Wang S; Liu Y; Li G; Feng Q; Hou M; Peng J
Thromb Res; 2021 Mar; 199():1-9. PubMed ID: 33383234
[TBL] [Abstract][Full Text] [Related]
32. Activation of Bak and Bax through c-abl-protein kinase Cdelta-p38 MAPK signaling in response to ionizing radiation in human non-small cell lung cancer cells.
Choi SY; Kim MJ; Kang CM; Bae S; Cho CK; Soh JW; Kim JH; Kang S; Chung HY; Lee YS; Lee SJ
J Biol Chem; 2006 Mar; 281(11):7049-59. PubMed ID: 16410245
[TBL] [Abstract][Full Text] [Related]
33. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
Zhang F; Chu X; Wang L; Zhu Y; Li L; Ma D; Peng J; Hou M
Eur J Haematol; 2006 May; 76(5):427-31. PubMed ID: 16480433
[TBL] [Abstract][Full Text] [Related]
34. Thrombopoietin and platelet production in chronic immune thrombocytopenia.
Kuter DJ; Gernsheimer TB
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1193-211. PubMed ID: 19932428
[TBL] [Abstract][Full Text] [Related]
35. [Determination of activated platelets: evaluation of methodology and application for patients with idiopathic thrombocytopenic purpura].
Hayashi S; Oshida M; Kiyokawa T; Aochi H; Honda S; Tomiyama Y; Kurata Y
Rinsho Byori; 2001 Dec; 49(12):1287-92. PubMed ID: 11797399
[TBL] [Abstract][Full Text] [Related]
36. An improved flow cytometric immunobead array to detect autoantibodies in plasma from patients with immune thrombocytopenic purpura.
Zhao Y; Zhu M; Jiang M; Zuo B; Wu Q; Ruan C; He Y
Clin Chim Acta; 2015 Jan; 438():396-400. PubMed ID: 25269089
[TBL] [Abstract][Full Text] [Related]
37. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Liebman HA
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
[TBL] [Abstract][Full Text] [Related]
38. Level of IL-16 and Reticulated Platelets Percentage during the Clinical Course of Immune Thrombocytopenic Purpura in Children.
Abd El-Glil RR; Assar EH
Egypt J Immunol; 2015; 22(1):29-40. PubMed ID: 26415370
[TBL] [Abstract][Full Text] [Related]
39. Changes in follicular helper T cells in idiopathic thrombocytopenic purpura patients.
Xie J; Cui D; Liu Y; Jin J; Tong H; Wang L; Ruan G; Lu Y; Yuan H
Int J Biol Sci; 2015; 11(2):220-9. PubMed ID: 25561904
[TBL] [Abstract][Full Text] [Related]
40. Functional role of CD4+CD25+ regulatory T cells and transforming growth factor-beta1 in childhood immune thrombocytopenic purpura.
Fahim NM; Monir E
Egypt J Immunol; 2006; 13(1):173-87. PubMed ID: 17974160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
